With relapsing forms of MS there’s a lot to deal with
Not just unpredictable relapses all these other things too
Who needs that kind of drama
Kesimpta is a once monthly injection that may
help you put this drama in its place
It reduce the rate of relapses and active lesions
And slow disability progression
Don’t take Kesimpta if you have hepatitis b
Kesimpta can cause serious side effects
Including infections especially when taken
before and after other medicines that weaken the immune system
Ask your healthcare provider about Kesimpta
Dramatic results, less RMS drama.
📽️ Video playback is currently unavailable for this commercial entry.
Plain Talk: About the Track
The music for the Kesimpta advertisement was created as an in-house production specifically for the “Less RMS Drama” campaign. In the pharmaceutical industry, background tracks are often composed to provide a steady, upbeat rhythm that allows for clear delivery of the extensive medical and safety disclosures required by law. As such, there is no public artist or commercial song title associated with this piece.
Kesimpta (ofatumumab) is a prescription medication produced by Novartis, a global healthcare leader formed in 1996 through the merger of Ciba-Geigy and Sandoz. Headquartered in Basel, Switzerland, Novartis utilizes this campaign to communicate a message of control and consistency for those living with Relapsing Multiple Sclerosis (RMS). The advertisement focuses on the convenience of a once-monthly at-home injection, framed by a soundtrack designed to feel modern and empowering.
Questions & Answers
What is Kesimpta used for?
Kesimpta is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS) in adults.
Who makes Kesimpta?
It is manufactured by Novartis, a pharmaceutical company based in Switzerland.
Why does the commercial have so much talking?
Pharmaceutical advertisements in certain countries are legally required to list potential side effects and safety information, known as “fair balance.”
